The laboratory diagnosis of Lyme borreliosis: Guidelines from the Canadian Public Health Laboratory Network

Canadian Journal of Infectious Diseases and Medical Microbiology

Volumn 18, Issue 2, 2007, Pages 145-148

  Kuschak, Theodore ^a  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

Borreliosis; Diagnosis; Lyme disease; Serology

Indexed keywords

CANADA; GEOGRAPHY; HUMAN; LABORATORY TEST; LYME DISEASE; MEDICAL ASSESSMENT; MEDICAL ERROR; PATIENT SELECTION; PHYSICIAN; PRACTICE GUIDELINE; PUBLIC HEALTH; REVIEW; SENSITIVITY AND SPECIFICITY;

EID: 34250323365     PISSN: 17129532     EISSN: None     Source Type: Journal    
DOI: 10.1155/2007/495108     Document Type: Review

References (23)

1. Steere AC, Malawista SE, Snydman DR, et al. Lyme arthritis: An epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum 1977;20:7-17.
2. Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E, Davis JP. Lyme disease - a tick-borne spirochetosis? Science 1982;216:1317-9.
3. Ogden NH, Ttudel L, Artsob H, et al. Ixodes scapularis ticks collected by passive surveillance in Canada: Analysis of geographic distribution and infection with the Lyme Borreliosis agent Borrelia burgdorferi. J Med Entomol 2006;43:600-9.
4. Morshed MG, Scott JD, Fernando K, et al. Distribution and characterization of Borrelia burgdorferi isolates from Ixodes scapularis and presence in mammalian hosts in Ontario, Canada. J Med Entomol 2006;43:762-73.
5. Morshed MG, JD Scott, Fernando K, et al. Migratory songbirds disperse ticks across Canada, and first isolation of the Lyme disease spirochete, Borrelia burgdorferi, from the avian tick, Ixodes auritulus. J Parasitol 2005;91:780-90.
6. Ogden NH, Barker IK, Beauchamp G, et al. Investigation of ground level and remote-sensed data for habitat classification and prediction of survival of Ixodes scapularis in habitats of southeastern Canada. J Med Entomol 2006;43:403-14.
7. Mullegger RR. Dermatological manifestations of Lyme borreliosis. Eur J Dermatol 2004;14:296-309.
8. Wormser GP. Clinical practice. Early Lyme disease. N Engl J Med 2006;354:2794-801.
9. Oschmann P, Dorndorf W, Hornig C, Schafer C, Wellensiek HJ, Pflughaupt KW. Stages and syndromes of neuroborreliosis. J Neurol 1998;245:262-72.
10. Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N Engl J Med 1990;323:1438-44.
11. Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP. Diagnosis of Lyme borreliosis. Clin Microbiol Rev 2005;18:484-509.
12. Nichol G, Dennis DT, Steere AC, et al. Test-treatment strategies for patients suspected of having Lyme disease: A cost-effectiveness analysis. Ann Intern Med 1998;128:37-48.
13. Robertson J, Guy E, Andrews N, et al. A European multicenter study of immunoblotting in serodiagnosis of Lyme borreliosis. J Clin Microbiol 2000;38:2097-102.
14. Engstrom SM, Shoop E, Johnson RC. Immunoblot interpretation criteria for serodiagnosis of early Lyme disease. J Clin Microbiol 1995;33:419-27.
15. Centers for Disease Control and Prevention (CDC). Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep 1995;44:590-1.
16. Bunikis J, Barbour AG. Laboratory testing for suspected Lyme disease. Med Clin North Am 2002;86:311-40.
17. Berger BW, Johnson RC, Kodner C, Coleman L. Cultivation of Borrelia burgdorferi from erythema migrans lesions and perilesional skin. J Clin Microbiol 1992;30:359-61.
18. Nocton JJ, Dressier F, Rutledge BJ, Rys PN, Persing DH, Steere AC. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med 1994;330:229-34.
19. Nocton JJ, Bloom BJ, Rutledge BJ, et al. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in Lyme neuroborreliosis. J Infect Dis 1996;174:623-7.
20. Carlson D, Hernandez J, Bloom BJ, Coburn J, Aversa JM, Steere AC. Lack of Borrelia burgdorferi DNA in synovial samples in patients with antibiotic treatment-tesistant Lyme arthritis. Arthritis Rheum 1999;42:2705-9.
21. Klempner MS, Schmid C, Hu L, et al. Intralaboratory reliability of serologic and urine testing for Lyme disease. Am J Med 2001;110:217-9.
22. Dressler F, Whalen JA, Reinhardt BN, Steere AC. Western blotting in the serodiagnosis of Lyme disease. J Infect Dis 1993;167:392-400.
23. Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: Clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006;43:1089-134.